Oorsprong van het eerstegraads netwerk van David A. DeLong
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David A. DeLong via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| The University of Colorado | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| INTERMUNE INC | Biotechnology | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Health Systems, Inc.
 Health Systems, Inc. Hospital/Nursing ManagementHealth Services Health Systems, Inc. provides health care services. The company is headquartered in Sikeston, MO. | Hospital/Nursing Management | Chairman | |
| COMMUNITY HEALTH SYSTEMS, INC. | Hospital/Nursing Management | Chairman | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Indiana University Health Foundation, Inc.
 Indiana University Health Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Indiana University Health Foundation, Inc. is a non-profit organization that operates to improve the health of individuals, communities, and the state of Indiana. The company was founded in October 18, 1961 and is headquartered in Indianapolis, IN. | Miscellaneous Commercial Services | Director/Board Member | |
Kovina Therapeutics, Inc.
 Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Chairman | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Wisconsin | College/University | Undergraduate Degree | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
BASF SA
 BASF SA Chemicals: Major DiversifiedProcess Industries Part of BASF SE, BASF SA is a Brazilian company that manufactures chemicals, paints, agricultural products and others. The company is based in São Paulo, Brazil. | Chemicals: Major Diversified | Sales & Marketing | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Pharmaceuticals: Major | Sales & Marketing | |
| Encore Retail GP LLC | Director/Board Member | ||
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chairman | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member | |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Director/Board Member | |
InCube Venture Partners LLC
 InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | Investment Managers | Private Equity Investor | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Investment Managers | Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
| University of Dayton | College/University | Masters Business Admin | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Verenigd Koninkrijk | 2 |
| Brazilië | 2 |
| Duitsland | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 5 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 105 |
| Independent Dir/Board Member | 29 |
| Corporate Officer/Principal | 21 |
| Chairman | 17 |
| Chief Executive Officer | 14 |
Sterkste connecties
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| William Ringo | 32 |
| Paul Berns | 28 |
| Timothy Patrick Lynch | 16 |
| Stewart John Hen | 15 |
| Marvin E. Jaffe | 13 |
| Jeremy Bender | 12 |
| James Caruso | 8 |
| Barbara E. Baring | 8 |
| David Clark | 7 |
| Marc H. Graboyes | 6 |
| Michael E. Hart | 4 |
| Michael E. Saunders | 2 |
| Donald J. Abraham | 1 |
- Beurs
- Insiders
- David A. DeLong
- Bedrijfsconnecties
